Blog

In mid-2025, Dyadic International (Nasdaq: DYAI) began a transformation that would reshape both its business model and its public image. The company, with a distinguished 40-year history as a science-driven…

Turning Science into Story for Investors, Analysts, and Advocates For an emerging biotech company, the period leading up to an IPO is an ideal opportunity to transform years of discoveries…

The Value of “Normal Course of Business” Communications During the IPO Quiet Period When a company enters the IPO registration phase, communications become a balancing act between transparency and restraint.…

Building the Discipline Before You Need It For companies preparing to go public, nothing tests credibility faster than a communications crisis. A misplaced comment, data leak, or unvetted social post…

Four phases to public listing success in a challenging market environment As companies navigate a route to public markets in late 2025, the IPO landscape in the biotechnology and life-sciences…

With some of the biggest investor and partnering conferences of the year approaching—including the 2026 JP Morgan Healthcare Conference, taking place January 12–15 in San Francisco—it’s essential to optimize your…